Boden G
Division of Endocrinology/Metabolism and Diabetes, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
Diabetes Care. 1996 Apr;19(4):394-5. doi: 10.2337/diacare.19.4.394.
We have demonstrated that physiological elevations in plasma free fatty acid concentrations inhibit insulin-stimulated glucose uptake in a dose-dependent manner in normal control subjects and in patients with NIDDM. Two possible mechanisms were identified: 1) a fat-related inhibition of glucose transport or phosphorylation that appeared after 3-4 h of fat infusion and 2) a decrease in muscle glycogen synthase activity that appeared after 4-6 h of fat infusion. We conclude that elevations of plasma FFAs caused insulin resistance and hence may play a significant role in the pathogenesis of insulin resistance in obesity and NIDDM.
我们已经证明,在正常对照受试者和非胰岛素依赖型糖尿病患者中,血浆游离脂肪酸浓度的生理性升高会以剂量依赖的方式抑制胰岛素刺激的葡萄糖摄取。确定了两种可能的机制:1)脂肪输注3-4小时后出现的与脂肪相关的葡萄糖转运或磷酸化抑制,以及2)脂肪输注4-6小时后出现的肌肉糖原合酶活性降低。我们得出结论,血浆游离脂肪酸升高导致胰岛素抵抗,因此可能在肥胖和非胰岛素依赖型糖尿病胰岛素抵抗的发病机制中起重要作用。